STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 15, 2025 |
Jun. 04, 2024 |
Apr. 11, 2024 |
Mar. 06, 2024 |
Oct. 18, 2024 |
Jun. 30, 2024 |
Jun. 24, 2024 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Feb. 01, 2026 |
Jul. 17, 2025 |
Oct. 31, 2024 |
Dec. 31, 2023 |
Jan. 31, 2022 |
Oct. 24, 2019 |
|
| Outstanding, option | 1,190 | 1,323 | 1,210 | 1,323 | 1,541 | ||||||||||||
| Stock based compensation expense | $ 7,243 | $ 139,678 | $ 485,432 | $ 729,712 | |||||||||||||
| Retained earnings (accumulated deficit) | $ (109,623,170) | $ (107,330,252) | $ (98,328,395) | ||||||||||||||
| common stock, par value | $ 0.00001 | $ 0.00001 | $ 0.00001 | ||||||||||||||
| Net income | $ (2,292,918) | (1,879,051) | $ (8,951,104) | $ (8,609,139) | |||||||||||||
| Series A Warrants [Member] | |||||||||||||||||
| Shares issued to holder | 1,603,370 | ||||||||||||||||
| Floor price of warrant shares | $ 7.60 | ||||||||||||||||
| True-up payment due to the remaining holders | $ 1,640,000 | ||||||||||||||||
| Additional warrants issued | 110,273 | ||||||||||||||||
| Floor price of true up payment | $ 4.71 | ||||||||||||||||
| True-up payment | $ 1,640,000 | ||||||||||||||||
| PIPE 2024 Offering [Member] | |||||||||||||||||
| Shares issued to holder | 19,110 | 920,324 | 162,129 | 162,129 | |||||||||||||
| Exercise price | $ 38 | ||||||||||||||||
| Exercise price warrant decrease | $ 682 | ||||||||||||||||
| Private investment in public equity offering | the Company agreed to issue an aggregate of 370,000 share of common stock at a purchase price of $1.55 per share, 920,324 pre-funded warrants to purchase shares of its common stock at $1.55 per share, 1,290,324 Series C Warrants, each to purchase one share of common stock at an initial exercise price of $1.30 per share, and 1,290,324 Series D Warrants to purchase one share of common stock at $1.30. The Company also issued 96,774 Placement Agent Warrants, each to purchase one share of common stock at $1.94. The aggregate net proceeds received by the Company from the offering were $1.7 million, net of commissions and offering expenses | the Company agreed to issue an aggregate of 370,000 share of common stock at a purchase price of $1.55 per share, 920,324 pre-funded warrants to purchase shares of its common stock at $1.55 per share, 1,290,324 Series C Warrants, each to purchase one share of common stock at an initial exercise price of $1.30 per share, and 1,290,324 Series D Warrants to purchase one share of common stock at $1.30. The aggregate net proceeds received by the Company from the offering were $1.7 million, net of commissions and offering expenses | |||||||||||||||
| Weighted-average exercise price | $ 47.30 | $ 9.60 | $ 9.60 | $ 9.60 | |||||||||||||
| Common stock, units issued | 202,470 | ||||||||||||||||
| Common stock, units issued, price per share | $ 40.50 | ||||||||||||||||
| common stock, par value | $ 0.00001 | ||||||||||||||||
| Proceeds from issuance of common stock | $ 902,541 | $ 1,652,034 | $ 1,652,034 | ||||||||||||||
| PIPE 2024 Offering [Member] | Series A Warrants [Member] | |||||||||||||||||
| Shares issued to holder | 579,219 | ||||||||||||||||
| Exercise price | $ 8.29 | ||||||||||||||||
| Exercise price warrant decrease | $ 8.29 | ||||||||||||||||
| Weighted-average exercise price | $ 8.39 | ||||||||||||||||
| Proceeds from issuance of common stock | $ 3,680,411 | ||||||||||||||||
| Additional warrants issued | 225,450 | ||||||||||||||||
| PIPE 2024 Offering [Member] | Series B Warrants [Member] | |||||||||||||||||
| Shares issued to holder | 640,864 | 640,864 | |||||||||||||||
| 2019 Equity Incentive Plan [Member] | |||||||||||||||||
| Number of authorized shares | 444,312 | 350,000 | 1,576 | ||||||||||||||
| Authorization of shares of common stock | 3,182 | 94,312 | 1,167 | ||||||||||||||
| Restricted Stock Units [Member] | |||||||||||||||||
| Stock based compensation expense | $ 0 | 15,524 | $ 62,095 | $ 62,095 | |||||||||||||
| Unvested RSUs granted to executive officers | 90 | ||||||||||||||||
| RSUs vested outstanding executive officers | 934 | 953 | 701 | ||||||||||||||
| RSUs unvested outstanding executive officers | 19 | 31 | 251 | ||||||||||||||
| Weighted average remaining contractual life | 4 years 11 months 12 days | 5 years 2 months 12 days | 5 years 2 months 12 days | ||||||||||||||
| Weighted average remaining vesting period | 12 years | ||||||||||||||||
| Common stock vested | 105 | ||||||||||||||||
| Restricted Stock Units [Member] | Minimum [Member] | Executive Officer [Member] | |||||||||||||||||
| Exercise price | $ 528 | $ 528 | $ 528 | ||||||||||||||
| Restricted Stock Units [Member] | Maximum [Member] | Executive Officer [Member] | |||||||||||||||||
| Exercise price | $ 2,552 | $ 2,552 | $ 2,552 | ||||||||||||||
| Stock Options [Member] | |||||||||||||||||
| Outstanding, option | 1,210 | 1,210 | 1,323 | ||||||||||||||
| Vested option shares | 1,190 | 1,176 | 1,048 | ||||||||||||||
| NonVested option shares | 20 | 34 | 275 | ||||||||||||||
| Unrecognized compensation expense | $ 12,172 | $ 119,143 | |||||||||||||||
| Stock based compensation expense | $ 7,243 | $ 124,154 | $ 423,337 | $ 667,617 | |||||||||||||
| Weighted avaerage unrecognized compensastion cost | 6 months | 4 years 9 months 18 days | |||||||||||||||
| Warrant Inducement [Member] | |||||||||||||||||
| Number of warrants to purchase common stock | 18,763 | ||||||||||||||||
| Total gross proceeds | $ 2,786,174 | ||||||||||||||||
| Net proceeds | 2,425,418 | ||||||||||||||||
| Retained earnings (accumulated deficit) | 341,297 | ||||||||||||||||
| Deemed dividend amount | 1,455,805 | ||||||||||||||||
| Commissions and transaction costs | $ 42,539 | $ 360,756 | |||||||||||||||
| Exercise price | $ 297 | ||||||||||||||||
| Warrants issued | 9,382 | ||||||||||||||||
| Exercise price warrant decrease | $ 297 | $ 297 | |||||||||||||||
| Stock Warrant [Member] | Consulting Agreement [Member] | |||||||||||||||||
| Common stock, shares issued | 4,198 | ||||||||||||||||
| Shares issued to holder | 5,184 | ||||||||||||||||
| Existing warrants shares | 9,382 | ||||||||||||||||
| Outstanding and reserved shares | 4,198 | ||||||||||||||||
| Armistice Warrants [Member] | |||||||||||||||||
| Exercise price | 1,485 | ||||||||||||||||
| Exercise price warrant decrease | $ 682 | ||||||||||||||||
| Net income | $ 23,270 | ||||||||||||||||
| Reduced current warrant exercise price per share | $ 1,485 | ||||||||||||||||
| Description of warrants | the September 2021 and the March 2022 Armistice Warrants as a result of the Inducement Letters, the Company issued an aggregate 2,418 warrants (the “Armistice Warrants”) consisting of (i) 1,934 warrants pursuant to the Adjustment terms under the September 2021 Armistice Warrant, and (ii) 484 warrants pursuant to the Adjustment terms of the March 2022 Armistice warrant | ||||||||||||||||